High-potency Class I to II topicals are frequently used first line to suppress inflammation and symptoms of itching. These agents are often useful as therapy for stage IA disease, but are often ...

Phototherapy involves the use of ultraviolet light for the treatment of skin disease and many dermatologists have phototherapy units in their offices. With these units, ultraviolet light of ...

Four major types have been characterized: extranodal T-cell lymphoma, cutaneous T-cell lymphomas (Sézary syndrome and Mycosis fungoides), anaplastic large cell lymphoma and angioimmunoblastic T ...

and potentially cutaneous T-cell lymphoma. All of these diseases have macrophage components and may show a beneficial response to local cutaneous therapy with immunotoxins such as these.

The following is a summary of “Integrative epidemiology and immuno-transcriptomics uncover a risk and potential mechanism for ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 CTCL Trial to Initiate Before End of 2024 Soligenix, Inc.

Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous T-cell lymphoma (CTCL) at the annual meeting of the European Organisation ...